Gengyin Zhou

2.2k total citations
61 papers, 1.8k citations indexed

About

Gengyin Zhou is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Gengyin Zhou has authored 61 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 24 papers in Oncology and 11 papers in Genetics. Recurrent topics in Gengyin Zhou's work include Drug Transport and Resistance Mechanisms (14 papers), Epigenetics and DNA Methylation (7 papers) and Estrogen and related hormone effects (6 papers). Gengyin Zhou is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Epigenetics and DNA Methylation (7 papers) and Estrogen and related hormone effects (6 papers). Gengyin Zhou collaborates with scholars based in China, Japan and United States. Gengyin Zhou's co-authors include Peng Su, Xiaofang Zhang, Peng Gao, Kennichi Kakudo, Takashi Ozaki, Lei Xiang, Zhiyan Liu, Yongping Cai, Jing Hu and Yanhua Bai and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Gengyin Zhou

61 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gengyin Zhou China 26 1.0k 545 366 223 199 61 1.8k
Hans-Juergen Schulten Saudi Arabia 28 764 0.8× 354 0.6× 337 0.9× 354 1.6× 195 1.0× 91 1.9k
Hisaya Kawate Japan 21 1.3k 1.3× 348 0.6× 319 0.9× 219 1.0× 286 1.4× 58 1.9k
Pawan Kumar United States 24 869 0.9× 761 1.4× 408 1.1× 163 0.7× 77 0.4× 64 1.9k
Ki Cheol Park South Korea 23 673 0.7× 333 0.6× 184 0.5× 195 0.9× 261 1.3× 49 1.4k
Kohei Shomori Japan 24 775 0.8× 397 0.7× 266 0.7× 286 1.3× 72 0.4× 66 1.6k
Hannes Neuwirt Austria 23 787 0.8× 548 1.0× 418 1.1× 148 0.7× 110 0.6× 62 1.8k
Karen Woodson United States 28 1.1k 1.1× 357 0.7× 420 1.1× 185 0.8× 162 0.8× 38 2.0k
Shoko Kure Japan 19 778 0.8× 871 1.6× 411 1.1× 179 0.8× 74 0.4× 41 1.8k
Bingyin Shi China 25 1.1k 1.1× 342 0.6× 355 1.0× 190 0.9× 460 2.3× 87 1.9k

Countries citing papers authored by Gengyin Zhou

Since Specialization
Citations

This map shows the geographic impact of Gengyin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gengyin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gengyin Zhou more than expected).

Fields of papers citing papers by Gengyin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gengyin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gengyin Zhou. The network helps show where Gengyin Zhou may publish in the future.

Co-authorship network of co-authors of Gengyin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Gengyin Zhou. A scholar is included among the top collaborators of Gengyin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gengyin Zhou. Gengyin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jing, Hui Zhang, Long Liu, et al.. (2020). TRPS1 Confers Multidrug Resistance of Breast Cancer Cells by Regulating BCRP Expression. Frontiers in Oncology. 10. 934–934. 10 indexed citations
2.
Qu, Ruize, Xiaohong Chen, Jing Hu, et al.. (2019). Ghrelin protects against contact dermatitis and psoriasiform skin inflammation by antagonizing TNF-α/NF-κB signaling pathways. Scientific Reports. 9(1). 1348–1348. 39 indexed citations
3.
Hu, Jing, Peng Su, Meng Jiao, et al.. (2018). TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program as a Negative Regulator of SUZ12. Translational Oncology. 11(2). 416–425. 26 indexed citations
4.
Xiao, Xiaoyan, et al.. (2015). Mycophenolate mofetil ameliorates diabetic nephropathy through epithelial mesenchymal transition in rats. Molecular Medicine Reports. 12(3). 4043–4050. 9 indexed citations
5.
Liu, Luying, Xuefang Xu, Lili Jing, et al.. (2015). Lysosomal-Associated Protein Transmembrane 4 Beta-35 Overexpression Is a Novel Independent Prognostic Marker for Gastric Carcinoma. PLoS ONE. 10(2). e0118026–e0118026. 11 indexed citations
6.
Sun, Yujing, Masako Nakanishi, Fuyuki Sato, et al.. (2014). Trps1 deficiency inhibits the morphogenesis of secondary hair follicles via decreased Noggin expression. Biochemical and Biophysical Research Communications. 456(3). 721–726. 6 indexed citations
7.
Sun, Yujing, Gengyin Zhou, Ting Gui, et al.. (2014). Elevated serum 1,25(OH)2-vitamin D3 level attenuates renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction in kl/kl mice. Scientific Reports. 4(1). 6563–6563. 13 indexed citations
8.
Hu, Jing, Weiwei Li, Peng Su, et al.. (2014). Trps1 is associated with the multidrug resistance of osteosarcoma by regulating MDR1 gene expression. FEBS Letters. 588(5). 801–810. 15 indexed citations
9.
Zhang, Xiaoying, Zhiyan Liu, Gengyin Zhou, et al.. (2012). Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma. Journal of Gastroenterology. 48(1). 132–143. 25 indexed citations
10.
Wu, Xiaojuan, Xiaofang Zhang, Hui Zhang, et al.. (2012). Progesterone receptor downregulates breast cancer resistance protein expression via binding to the progesterone response element in breast cancer. Cancer Science. 103(5). 959–967. 17 indexed citations
11.
Zhang, Xiaofang, Xiaojuan Wu, Peng Su, et al.. (2012). Doxorubicin Influences the Expression of Glucosylceramide Synthase in Invasive Ductal Breast Cancer. PLoS ONE. 7(11). e48492–e48492. 25 indexed citations
12.
Mu, Kun, Li Li, Tingguo Zhang, et al.. (2011). Detection of CHK1 and CCND1 gene copy number changes in breast cancer with dual‐colour fluorescence in‐situ hybridization. Histopathology. 58(4). 601–607. 12 indexed citations
13.
Gao, Peng, Jishu Wei, Ping Li, et al.. (2010). Screening of deoxyribozyme with high reversal efficiency against multidrug resistance in breast carcinoma cells. Journal of Cellular and Molecular Medicine. 15(10). 2130–2138. 6 indexed citations
15.
Zhang, Cuijuan, Yan Wang, Wenjun Liu, et al.. (2010). Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. Journal of Hepatology. 53(5). 889–895. 57 indexed citations
16.
Chen, Tingting, Gengyin Zhou, Quan Zhu, et al.. (2010). Overexpression of Vascular Endothelial Growth Factor 165 (VEGF165) Protects Cardiomyocytes Against Doxorubicin-Induced Apoptosis. Journal of Chemotherapy. 22(6). 402–406. 20 indexed citations
17.
Wang, Xiao, et al.. (2009). The Mammographic Correlations with Basal-Like Phenotype of Invasive Breast Cancer. Academic Radiology. 17(3). 333–339. 7 indexed citations
18.
Bai, Yanhua, Kennichi Kakudo, Misa Nakamura, et al.. (2009). Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma and periostin expression. Cancer Letters. 281(2). 188–195. 38 indexed citations
19.
Zhang, Tingguo, Peng Gao, Bin Meng, et al.. (2009). Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs. Breast Cancer Research and Treatment. 121(3). 591–599. 26 indexed citations
20.
Wei, Fulan, Chunling Wang, Gengyin Zhou, et al.. (2007). The effect of centrifugal force on the mRNA and protein levels of ATF4 in cultured human periodontal ligament fibroblasts. Archives of Oral Biology. 53(1). 35–43. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026